Measuring quality of life in early HIV disease: The modular approach

Quality of Life Research

Volumn 6, Issue 6, 1997, Pages 515-530

  Lenderking, W R ^a,b,c   Testa, M A ^b   Katzenstein, D ^d   Hammer, S ^e  

^a Phase V Technologies Inc   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antiviral therapy; CD4; HIV infection; Modular approach; Quality of life; Symptoms

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DISCRIMINANT ANALYSIS; ETHNIC GROUP; HEALTH CARE UTILIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; DRUG EVALUATION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0030749347     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018408115729     Document Type: Conference Paper

References (38)

1. Gelber RD, Lenderking WR, Cotton DJ et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Ann Intern Med 1992; 116(12): 961-966.
2. Lenderking WR, Gelber RD, Cotton DJ et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. New Engl J Med. 1994; 330: 738-743.
3. Wu AW, Mathews WC, Brysk LT et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J AIDS 1990; 3: 683-690.
4. Wu AW, Rubin HR, Mathews WC et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early AIDS-related complex. J AIDS 1993; 6: 452-458.
5. Wu AW, Rubin HR. Measuring health status and quality of life in HIV and AIDS. Psychol Health 1992; 5: 251-264.
6. Cleary PD, Fowler FJ, Weissman J et al. Health-related quality of life in persons with AIDS. Med Care 1993; 31: 569-580.
7. Hays RD, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1992; 1: 91-97.
8. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Nat Cancer Inst 1993; 85(5): 365-376.
9. Aaronson NK. The EORTC approach to quality-of-life assessment. In: Fourth International Symposium on Supportive Care in Cancer, St Gallen, Switzerland, 24-27 February, 1993.
10. Aaronson NK, Meyerowitz Be, Bard M et al. Quality of life research in oncology: past achievements and future priorities. Cancer 1991; 67 Suppl 3: 839-843.
11. Testa MA, Lenderking WR. Quality-of-life considerations in AIDS clinical trials. In: Finkelstein DM, Schoenfeld DA, eds, AIDS Clinical Trials. New York: Wiley-Liss; 1995; 213-241.
12. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992; 116: 129-137.
13. Tarlov AR. Outcomes assessment and quality of life in patients with human immunodeficiency virus infection. Ann Intern Med 1992; 116: 166-167.
14. Patrick D, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press, 1992.
15. World Health Organization. Constitution of the World Health Organization. Basic Documents. World Health Organization, 1948.
16. Lenderking WR, Worth JL, Beckett A. Quality-of-life assessment in HIV-infected psychiatric outpatients: perceived health, functional status, symptoms, and preferences for cardiopulmonary resuscitation. Psychol Health 1994; 9:51-64.
17. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359-366.
18. Hammer SM, Katzenstein DA, Hughes MD et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts between 200 and 500 per cubic millimeter. New Engl J Med 1996; 335: 1081-1090.
19. Croog SH, Levine S, Testa MA et al. The effects of antihypertensive therapy on the quality of life. New Engl J Med 1986; 314: 1657-1664.
20. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertension 1991; 4: 363-373.
21. Testa MA, Simonson DC. Measuring quality of life in hypertensive patients with diabetes. Postgrad Med J 1988; 64 Suppl 3: 50-58.
22. Bombardier C, Ware J, Russell IJ et al. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med 1986; 81: 565-578.
23. Levine S. The changing terrains in medical sociology: emergent concern with quality of life. J Health Soc Behav 1987; 28: 1-6.
24. Stewart AL, Hayes RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 724-735.
25. Jette AM, Davies AR, Cleary PD et al. The functional status questionnaire: reliability and validity when used in primary care. J Gen Int Med 1986; 1: 143-149.
26. Stewart AL, Sherbourne CD, Hayes RD et al. Summary and discussion of MOS measures. In: Stewart AL, Ware JC, eds. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University, 1992; 345.
27. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: Nimrod Press, 1993.
28. Berry SH, Bozzette SA, Hays RD et al. Measuring Patient Reported Health Status and Experience in Advanced HIV Disease: the HIV-PARSE Survey Instrument. Santa Monica, CA: RAND, 1994.
29. Wu A, Rubin HR, Mathews WC et al. A health status questionnaire using 30 items from the Medical Outcomes Study, preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786-798.
30. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
31. Nunnally JC. Psychometric Theory, 2nd edn. New York: McGraw-Hill, 1978.
32. Perry SW. Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am J Psychiat 1989; 147(6): 696-710.
33. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
34. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A perceived health index for use in persons with advanced HIV disease: derivation, reliability, and validity. Med Care 1994; 32: 716-731.
35. DeBoer JB, van Dam FSAM, Sprangers MAG. Health-related quality-of-life evaluation in HIV-infected patients: a review of the literature. Pharmacoeconomics 1995; 8(4): 291-304.
36. Burgess A, Dayer M, Catalan JK, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health-related quality-of-life measures: a preliminary analysis. AIDS 1993; 7: 1001-1008.
37. Lenderking WR, Gortmaker S, Fowler M et al. for the AIDS Clinical Trials Group. Quality of Life in Pediatric HIV Infection. Washington DC: 1994.
38. Clark C, Gortmaker S, Lenderking WR, Oleske J for the ACTG Protocol 219 Team. Quality of Life in Children Enrolled in ACTG 219. Washington, DC: 1995.